Timothy Malinowski
Gerontology · Greenville, SCNPI 1740893593
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (58.3%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 28 manufacturers reported payments, led by Endotronix, Inc. at 42.7% of the total. 2025 is the largest year on record at $42,970, more than ten times the $886 reported in 2021. Among gerontology clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 326 payments — averaging $151.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Endotronix, Inc.$21K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$16K
- Edwards Lifesciences$5K
- Analog Devices Inc.$1K
- Kestra Medical Technology Services, Inc.$975
- Novartis$886
- plus $5K from 22 others
What the payments were for
- Consulting fees$28,85658%
- Speaking & faculty fees$6,50013%
- Travel & lodging$5,85412%
- Food & beverage$8,26117%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Endotronix, Inc. | 8 | $21,112 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 73 | $15,507 |
| Edwards Lifesciences | 2 | $5,195 |
| Analog Devices Inc. | 2 | $1,250 |
| Kestra Medical Technology Services, Inc. | 26 | $975 |
| Novartis | 54 | $886 |
| Cvrx, Inc. | 25 | $680 |
| Boehringer Ingelheim | 25 | $463 |
| AstraZeneca | 18 | $446 |
| Impulse Dynamics (USA) Inc. | 10 | $359 |
| United Therapeutics Corporation | 5 | $294 |
| Boston Scientific | 6 | $277 |
| Actelion Pharmaceuticals US, Inc. | 9 | $270 |
| Abiomed | 4 | $264 |
| Abbott | 9 | $259 |
| Scpharmaceuticals Inc. | 7 | $220 |
| Bridgebio Pharma, Inc. | 5 | $192 |
| E.r. Squibb & Sons, L.L.C. | 7 | $179 |
| Alnylam Pharmaceuticals Inc. | 6 | $139 |
| Merck | 4 | $119 |
| Johnson & Johnson | 4 | $86 |
| Amgen | 5 | $85 |
| Pfizer | 4 | $65 |
| Bayer | 3 | $60 |
| Daiichi Sankyo Inc. | 2 | $44 |
| Lexicon Pharmaceuticals, Inc. | 1 | $17 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $16 |
| Medtronic | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CORDELLA PULOMONARY ARTERY PRESSURE SENSOR$20,040
- LifeVest$14,365
- Sensinel CPM Wearable$1,250
- CORDELLA PULMONARY ARTERY PRESSURE SENSOR$1,000
- Assure WCD$350
- OPTIMIZER$303
- Barostim Neo System$258
- GENERAL - THERAPIES$168
- Impella$166
- CAMZYOS$122
- FARXIGA$118
- CARDIOMEMS$113
- REMODULIN$107
How this compares
$49,471 in reported general payments places this provider in the 95th percentile of 137 gerontology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OpsumitMacitentan | 29 | $361,779 |
| EntrestoSacubitril/Valsartan | 170 | $177,305 |
| JardianceEmpagliflozin | 161 | $155,488 |
| EliquisApixaban | 152 | $122,462 |
| FarxigaDapagliflozin Propanediol | 72 | $56,848 |
| Torsemide | 428 | $15,524 |
| Sildenafil Citrate | 27 | $12,633 |
| Repatha SureclickEvolocumab | 13 | $11,008 |
| Bumetanide | 70 | $6,896 |
| Spironolactone | 293 | $3,057 |
| Potassium Chloride | 90 | $2,753 |
| Eplerenone | 27 | $2,048 |
| Metoprolol Succinate | 173 | $2,032 |
| Tadalafil | 20 | $1,462 |
| Midodrine Hcl | 29 | $1,317 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Actelion Pharmaceuticals US, Inc.Opsumit | $270 | $361,77929 claims |
| NovartisEntresto | $886 | $177,305170 claims |
| Boehringer IngelheimJardiance | $463 | $155,488161 claims |
| PfizerEliquis | $65 | $122,462152 claims |
| AstraZenecaFarxiga | $446 | $56,84872 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 137 gerontology providers in South Carolina.
Other gerontology in Greenville
- Kathryn RarickGreenville$10K
- Rachael WillsGreenville$8K
- Karen CainGreenville$8K
- Sarah BramonGreenville$6K
- Gina FultonGreenville$5K
- Catherine BrickleyGreenville$4K
- Heather Holweger-GarciaGreenville$3K
- Lucinda SmithGreenville$3K
- Margaret GalipeauGreenville$3K
- Laura FreemanGreenville$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.